01/04/21 -"For FY20/21, EPS improved relative to our expectations on the back of better-than-expected non-recurring cost savings. In the subsequent years, we take a more optimistic stance on profitability ..."
Pages
49
Language
English
Published on
01/04/21
You may also be interested by these reports :
31/10/25
Avolta’s Q3 results slightly missed consensus expectations. While growth was robust across all regions, North America continued to experience some ...
30/10/25
Galenica’s YTD 2025 sales reached CHF 2,999.7 million, growing by 4.7%. This growth was driven by strong tailwinds from prescription drugs, ...
29/10/25
3Q25: Adj. EBITDA exceeded expectations – Confirmed FY25E guidance
16/10/25
Travis Perkins’ Q3 FY25 results showed 1.8% yoy lfl sales growth, slightly beating market expectations, driven by gains in merchanting and ...